Targeting progression and drug resistance in Triple Negative Breast Cancer | Regional Centre for Biotechnology

Targeting progression and drug resistance in Triple Negative Breast Cancer

Targeting progression and drug resistance in Triple Negative Breast Cancer

Targeting progression and drug resistance in Triple Negative Breast Cancer

Targeting progression and drug resistance in Triple Negative Breast Cancer

Nandini Verma, Department of Molecular Cell Biology Weizmann Institutr of Science, Israel

23-01-2018 08:30:00

RCB News

RCB-UCSD Certificate Course on Data Analysis for Systems Biology

CBC2.0

Curtain Raiser Program – IISF 2025 at RCB

i3c BRIC-RCB Leadership Talk

Visit from Sharda University, Greater Noida

What's New

Result of Six-Month to One-Year Research Training Programme: January, 2026 to June, 2026

List of candidates provisionally shortlisted for the interview to the Post Graduate Diploma in Industrial Biotechnology 2025-2026

List of Provisionally Shortlisted and Not Shortlisted List of Candidates List for RCB PhD Interview (Autumn Semester 2025–26)

Recruitment of Finance Officer: Notification of Screening

Hands-on Training Workshop on ‘Gene Editing in Plants: From CRISPR Design to Analysing Edited Lines

BITP EXAM RESULT 2025-26

Admissions to the Postgraduate Diploma in Industrial Biotechnology (The last date of receipt of the application for the PGDIB programme has been extended till 25.11.2025)

Innovation Challenge 'SPARK 2025'

PhD Programme in Biotechnology Admissions 2025-26 (Autumn Semester)(The last date for submitting online applications is 15.11.2025)

The position advertised at serial no.2 of the advertisement no. RCB/Consultants/04/2025/HR dated 18.08.2025 stands withdrawn

The deadline for inviting applications for the position of Dean has been extended till 22.10.2025.

Previous Pause Next

Accessibility Tools